• UCB, Roche lead new investments in UK's life sciences sector firstwordpharma
    December 05, 2018
    UCB will invest 1 billion pounds ($1.3 billion) in R&D in the UK over the next five years, including the construction of a new facility, as part of the UK Government's life sciences industrial strategy outlined on Wednesday.
PharmaSources Customer Service